Targeting IGF2-IGF1R Signaling to Reprogram the Tumor Microenvironment for Enhanced Viro-Immunotherapy.
Noh MH, Kang JM, Miller AA, Nguyen G, Huang M, Shim JS, Bueso-Perez AJ, Murphy SA, Rivera-Caraballo KA, Otani Y, Kim E, Yoo SH, Yan Y, Banasavadi-Siddegowda Y, Nakashima H, Chiocca EA, Kaur B, Zhao Z, Lee TJ, Yoo JY.
Noh MH, et al. Among authors: yoo sh.
Neuro Oncol. 2024 Jun 10:noae105. doi: 10.1093/neuonc/noae105. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38853689